Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 LifeCycle Pharma A/S | Contract Pharma
Breaking News, Promotions & Moves

LifeCycle Pharma A/S

Dr. William J. Polvino has been named president and chief executive officer of LifeCycle Pharma

Dr. William J. Polvino has been named president and chief executive officer of LifeCycle Pharma. He was previously the company’s chief operating officer.

“We are very pleased to announce that Dr. Polvino has accepted the position as CEO and President of LCP,” said Paul Edick, LCP’s chairman. “During his relatively short tenure at LCP, Dr. Polvino has contributed to the progress in our clinical program and showed strong leadership in the organization in order to make best use of the opportunities and challenges of LCP’s current and future product pipeline,”

Dr. Polvino was appointed chief operating officer in August 2009 and brought extensive experience in the senior management of pharmaceutical companies together with solid experience in clinical as well as product development. Prior to joining LCP he was chief executive officer at Helsinn Therapeutics US. Previously, in his capacity as the president and chief executive officer of Sapphire Therapeutics, he successfully advanced the company’s pipeline products, ultimately leading to the sale of the company to Helsinn.

He joined the life science industry in 1991 and held various positions of increasing responsibility within clinical research, drug development, and senior positions at Merck, Wyeth, Theravance and Sapphire.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters